Soo-youl Y. Kim
Tumor Microenvironment Branch
Goyang, Republic of Korea
Goyang, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Inhibiting Fatty Acid Oxidation Reverses Autophagy-Mediated Acquired Chemotherapy Resistance in Pancreatic Ductal Adenocarcinoma.
Journal: Cancer research
Published: October 05, 2025
Inhibiting Fatty Acid Oxidation Suppresses Acquired Resistance to Standard Chemotherapy in Melanoma.
Inhibiting Fatty Acid Oxidation Suppresses Acquired Resistance to Standard Chemotherapy in Melanoma.
Journal: International journal of molecular sciences
Published: September 22, 2025
Pharmacological transglutaminase 2 inhibition enhances temozolomide response in patient-derived glioblastoma tumorspheres.
Journal: Journal of neuro-oncology
Published: August 29, 2025
Transglutaminase 2 exacerbates ovarian cancer survival by directly inactivating GSK3β.
Journal: Cell death & disease
Published: August 05, 2025
ACAA1 knockout increases the survival rate of KPC mice by activating autophagy.
Journal: Molecular metabolism
Published: June 30, 2025
Fatty acid addiction in cancer: A high-fat diet directly promotes tumor growth through fatty acid oxidation.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: May 27, 2025
Nutrient Availability Dictates Cancer Metabolism-Based Therapeutic Responses to Nononcology Drugs.
Journal: Cancer research
Published: March 12, 2025
N-phenylmaleimide induces bioenergetic switch and suppresses tumor growth in glioblastoma tumorspheres by inhibiting SLC25A11.
Journal: Cancer cell international
Published: September 06, 2024
Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinoma.
Journal: Bioorganic chemistry
Published: November 08, 2023
Last Updated: 09/26/2026